Last Post !

This is the final post of this Summer term. It was a pleasure sharing all the information and learning from other students' posts; this truly has been a great learning experience. Even though this semester has been too short and hectic, I really feel like I have added a tremendous amount of information to my knowledge.

These posts have increased my knowledge in the topic area, especially when it comes to thrombocytosis and its different focus areas in children.

I have tried to find new interesting topics that relate to us as future medical technologists, and I hope that you have found my posts useful!

Thank you so much for a great semester, and will see you all in the next one.

Hepatitis B

Hepatitis B is an infection caused by Heptatitis B Virus, and is divided into 2 types:

-       Acute Hepatitis B: newly acquired infections. Symptoms usually appear after 1 to 4 months of infecion. Symptoms usually resolve for most patients after few months, with a small number of patients developping fulminant hepatitis, which a life-threatening form of acute hepatitis.

-       Chronic hepatitis B are patients who symptoms did not resolve completeley, lasting longer than 6 months. Chronic hepatitis B infection is permanent. Chronic hepatitis B infection is more prominent and severe in children.

Transmission: HBV is a blood borne virus, transmitted through blood or mucous. Moreover, it is transmitted from infected pregnant mother to fetus. People at high risk of getting infected with HBV virus include: sexual relationship with an infected person, illicit drug use, needle stick in case of healthcare workers and clinical laboratory workers, newborns for mothers with infection.

HBV virus enters the host cells by binding to an unknown receptor, and being endoctyosed. Chaperones transfer the viral DNA to host nucleus where its DNA is transformed into covalently closed circular DNA from whcih four viral mRNAs are made. Those newly formed mRNA are used to make new copies of the viral genome and capsid core protein and viral DNA polymerase. These then undergo further processing to from virions that are released from the cell for further infection or return to the nucleus to make more copies.

Early symptoms of HBV infection include: fatigue, itching, appetite loss, jaundice, dark urine, clay colored stool and nausea and vomiting and dehydration. Patients experience fulminate HBV infection also experience symptoms associated with hepatic encephalopathy.  

http://www.britishlivertrust.org.uk/data/5/content/6/628/imgs/HBV%20Nat%20Hist.JPG

Thrombocytosis Treatment and Medical Care

Treatment of thrombocytosis should be individualized based on risk factors, which include: cardiovascular risk factors(smoking, hypertension, etc.), thrombocytosis histroy, Platelet count greater than 1.5 million x 109/L.

Hydroxyurea, interferon alfa and anagrelide are drugs among treatment of choice for thrombocytopenia. Low dose aspirin has also shown some benefit during treatment. Moreover, plateletpheresis has shown to be beneficial for a prompt decrease in platelet count is case of emergencies and acute

Lifestyle modifications such as smoking cessation, weight loss and exercise are essetial to patients with primary thrombocytosis. Studies have shown the benefit of hydroxyurea treatment for patients with thrombocytosis in decreasing the platelet count; moreover, a clinical trial has shown the overall benefit of taking hydroxyurea and aspirin over anagrelide and aspiring combination, as far as thrombocytosis treatment and less experienced side effects and risk for the patient. Another clinicla control trial has shown that low-dose aspirin by itself may be beneficial in treatment of low-risk patients. 

http://bloodjournal.hematologylibrary.org/content/117/5/1472.full

Link Between Air Pollution and Decreased Immunity Against Mycobacterium Tubeculosis

The alveolar macrophages play a major role in protecting the host against airborne pathogens. However, environmental health scientist showed a major concern on the ability of the environment chemicals to affect the immunological function of these cells.

A recent research has confirmed the existence of a relation between air pollution and decreased immunity against Mycobacterium tubeculosis. The exposure of human to diesel exhaust particles inhibit phagocytic cells. The research was conducted performing experiments that study the ability of phagocytic cells to fight TB in the presence or absence of DEP. After comparing the results, the researchers were able to prove that cells of the immune system become desensitized and less able to fight TB after exposure to air pollution.

The inhibition of the immune system can be exlpained by dysregulation of chemokine and cytokine production, the inability of phagocytic cell to migrate, and the loss of the phagocytosis potential. The effect of air pollution does not only leave the host vulnerable to TB infection but also lead to modifications in other macrophages mechanisms that are essential for pathogen clrearance.

Current statistics state that TB affect ten million people worldwide and cause the death of 1.5 million people per year. The prevalence of the disease is especially high in developing countries that are experiencing sudden industrial growth associated with a increase in air pollution. In addition, a study have shown that by 20 years from now 50% of the population will be moving to urban environment. All this is an indication that TB will keep on affecting a higher number of the population worldwide.

http://www.public.asu.edu/~shaydel/research_001tb_2.html

Laboratories Testing for Differentiating Primary from Secondary Thrombocytosis in a Pediatric Patient

When a pediatric patient presents with thrombocytosis, laboratory studies are performed to be able to determine whether it is a condition of primary thrombocytosis or secondary thrombocytosis. No additional studies need to be performed when physicians strongly suspect  primary thrombocytosis . However, several lab testing can help  differentiate secondary from primary thrombocytosis.  Fibrinogen level, acute phase reactants, C-reactive protein, von Willebrand factor and factor VIII are found to be remarkably elevated in pediatric patients with secondary thrombocytosis but normal in case of primary thrombocytosis. In the beginning of reactive thrombocytosis, serum TPO levels can be elevated; But with the progression of the disease TPO can return to normal values. Therefore, it is very important to carefully interpret TPO serum values in a timely manner. Whereas in case of primary thrombocytosis induced by  a mutation in 5’ UTR (5’ untranslated region), which  play a role in inhibition of TPO mRNA,  elevated value of TPO would be present all the time. Nevertheless, essential thrombocytosis due to other mutation can have normal TPO levels.  The most common mutation in essential thrombocytosis is JAK2 mutation, thus when essential thrombocytosis is suspected we always test for JAK2 mutation.

                                           http://spittoon.23andme.com/wp-content/uploads/2012/03/MPN-progression.png

This is an algorithm that presents suggested work-up for platelet count that are over 1 million/μL:

                                                         http://emedicine.medscape.com/article/959378-workup

Patient Guidelines for Antibiotics Use

Antibiotic resistance has a great impact on increased morbidity and mortality in patients with infections due to resistant organisms. It is important for us as healthcare professionals to increase the awareness of drug resistance for the general public, and its great influence on our societies and quality of life in the long run. Overuse and misuse of antibiotic administration is the primary cause of antibiotic resistance.  Moreover, antibiotic misuse even in other fields such as agricultural field will contribute significantly to antibiotic resistance in humans.

Therefore, Antibiotic resistance can only be managed through proper use and administration of antibiotics.

                                          http://scienceinthetriangle.org/wp-content/uploads/2011/02/antibiotic-resistance-graph1.jpg

This is a guideline, intended for patients, that provides guidance on the appropriate use of antibiotics:

-       Proper education of the patient for antibiotic use is vital. Patients should be taught to not expect antibiotics for every ailment. Physicians should perform thorough investigation of illness and determine the best course of therapy.

-       Ask your health practitioner or pharmacist for specific information on how to use the antibiotics. Also, read and understand the drug information provided by the pharmacist.

-       Always finish the therapy by taking the entire course of antibiotics, even when symptoms become better.

-       Follow proper schedules for antibiotics.

-       Determine if the antibiotic needs to be taken with food or not. Food intake might affect the absorption of certain drugs and improper food intake can lead to sub-therapeutic levels of certain antibiotics.

-       Do not take any antibiotics if not prescribed to you by a licensed health practitioner.

The Utility of Platelet Count as a Potential Predictor of Infant Bacterial Infection

 

The evaluation of an infant with febrile illness and no obvious focus of infection is one of the main challenging job that faces pediatricians. The general condition of the infant can generally be deceptive, and is labeled Serious Bacterial Infection (SBI). Laboratory markers that have been used to predict SBI include raised white blood cell (WBC) counts, C-reactive protein, pro-calcitonin and even interleukin-6 levels. White blood cell count by itself, does not compare well with relatively more recent markers such as C-reactive protein and pro-calcitonin.

A new study revises the relationship between reactive thrombocytosis among febrile infants and assesses the utility of platelet count as a potential predictor of serious bacterial infection in these patients.

The mean platelet count in SBI infants was observed to be significantly higher than non-SBI infants. Infections of the respiratory, urinary and gastrointestinal tracts, as well as bones and meninges were the most common causes of reactive thrombocytosis.  A platelet count of > 45,000/mL in addition to other laboratory data such as WBC> 15,000 mL and CRP ≥2mg/dL was a strong indicator of SBI.

The study asserts the addition of a routine hematology parameter like platelet count to the sepsis screen results in better differentiating between SBI and non-SBI infants, which delineates the severity of the infection and the extent of the treatment. This finding might be useful in the ER  and in pediatrics where quick turnaround time is necessary. 

                                                         http://physiologyonline.physiology.org/content/17/1/6/F3.large.jpg